Mutual Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
Mutual Advisors's DGX Position: Q1 2026 in Review
Mutual Advisors increased its Quest Diagnostics (DGX) stake by 7.4% in Q1 2026, buying an estimated $18.8K and bringing the position to 1,415 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #1153.
Mutual Advisors first reported a position in DGX in Q1 2021 and has held it in 18 quarters since. The position peaked at $578K in Q2 2023. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Mutual Advisors held 1,415 shares of Quest Diagnostics worth $277K as of Q1 2026.
- Mutual Advisors bought 97 Quest Diagnostics shares in Q1 2026, an estimated $18.8K.
- Quest Diagnostics made up 0.01% of Mutual Advisors's portfolio in Q1 2026, its #1153 holding.
- Mutual Advisors first reported a position in Quest Diagnostics in Q1 2021 and has held it in 18 quarters since.
- Mutual Advisors's Quest Diagnostics position peaked at $578K in Q2 2023.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.